{"id":830925,"date":"2025-03-27T17:10:06","date_gmt":"2025-03-27T21:10:06","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/teva-releases-q1-2025-aide-memoire\/"},"modified":"2025-03-27T17:10:06","modified_gmt":"2025-03-27T21:10:06","slug":"teva-releases-q1-2025-aide-memoire","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/teva-releases-q1-2025-aide-memoire\/","title":{"rendered":"Teva Releases Q1 2025 Aide Memoire"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">TEL AVIV, Israel, March  27, 2025  (GLOBE NEWSWIRE) &#8212; Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that its Q1 2025 Aide Memoire is available on the \u201cInvestors\u201d page on its website.<\/p>\n<p>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Wf-diaoS2M5RnQje2Am60iBZDBpsl7bJVwPYVD5EqUJ5_ZMay0D8Al2PoWXB43LhzZ8nOB89KTjynlyYfngug1mfp4JyeDv-jMk89NP7GbwXH8qcixgWhuBX9k4Kt9kbE5GKHb1qb7EeF9-tI6Z8lkgXBhpUcPjbjTDzSwv9XxI=\" rel=\"nofollow\" target=\"_blank\">Q1 2025 Aide Memoire<\/a>\n      <\/p>\n<p>Teva has prepared this document to assist in the financial modeling of its quarterly results. The document is based on Teva\u2019s prior results, management\u2019s previous commentary about Teva\u2019s business outlook and data from select independent sources. Going forward, it is Teva\u2019s intention to provide this information towards the end of each quarter.<\/p>\n<p align=\"justify\">\n        <strong>About Teva<\/strong>\n      <\/p>\n<p>Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) is a different kind of global biopharmaceutical leader, one that operates across the full spectrum of innovation to reliably deliver medicines to patients worldwide. For over 120 years, Teva\u2019s commitment to bettering health has never wavered. Today, the company\u2019s global network of capabilities enables its 37,000 employees across 57 markets to advance health by developing medicines for the future while championing the production of generics and biologics. We are dedicated to addressing patients\u2019 needs, now and in the future. Moving forward together with science that treats, inspired by the people we serve. To learn more about how Teva is all in for better health, visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=iClx_WV4E2_BENCT7ID1KYHq2Xl12mtNjM0jpUGQkBwLt1H47YKs43NbCLsnCg4lYRJIYnI4j4TSfYS_qbPTu0AvwzUJcKUYMSY9I70KDB0=\" rel=\"nofollow\" target=\"_blank\">www.tevapharm.com<\/a>.<\/p>\n<p align=\"justify\">\n        <strong>Cautionary Note Regarding Forward-Looking Statements<\/strong>\n      <\/p>\n<p align=\"left\">This press release and the conference call may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, which are based on management\u2019s current beliefs and expectations and are subject to substantial risks and uncertainties, both known and unknown, that could cause our future results, performance or achievements to differ significantly from that expressed or implied by such forward-looking statements. Important factors that could cause or contribute to such differences include risks relating to: our ability to successfully compete in the marketplace including our ability to successfully execute our Pivot to Growth strategy; our significant indebtedness; our business and operations in general; compliance, regulatory and litigation matters; other financial and economic risks; and other factors discussed in this press release, in our Annual Report on Form 10-K for the year ended December 31, 2024, including in the sections captioned &#8220;Risk Factors\u201d and &#8221; Forward-looking Statements.\u201d Forward-looking statements speak only as of the date on which they are made, and we assume no obligation to update or revise any forward-looking statements or other information contained herein, whether as a result of new information, future events or otherwise. You are cautioned not to put undue reliance on these forward-looking statements.<\/p>\n<p>Teva Media Inquiries<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=4zhvAtQXrEueNWHlbQZnNm8f6YXiC_ptRRWTONTnZKjtXk15JZq4Pi81QkWYpWKo7ia-KDR4h_r3H4UzlLsHXf-p2DnW-iIIAiYDXwImFkjA6L0ywtc2cGLzCuAKk5tp_bDlvIhtBDVmP4GNlV1VYbi8muyYLXuWlt94QFZubsw=\" rel=\"nofollow\" target=\"_blank\"><u>TevaCommunicationsNorthAmerica@tevapharm.com<\/u><\/a><\/p>\n<p>Teva Investor Relations Inquires<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=4zhvAtQXrEueNWHlbQZnNoX9pX190gPlYAPTBtSNbBjW8SAx7tzM9Z15opIudq3U5PRBp02-EYrT9P3nkBGk36cF0MfCKZIA2VE7Ys7hgGg=\" rel=\"nofollow\" target=\"_blank\"><u>TevaIR@Tevapharm.com<\/u><\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTA3NjYxOSM0MDIxMDM0MzcjMjAwMzA3Nw==\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml-eu.globenewswire.com\/media\/YmYyYmM2NGItOTViOS00NTQ1LTgxODEtMTRhZmM0YjUwZGFkLTEwMTQ2NTAtMjAyNS0wMy0yNy1lbg==\/tiny\/Teva-Pharmaceutical-Industries.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>TEL AVIV, Israel, March 27, 2025 (GLOBE NEWSWIRE) &#8212; Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that its Q1 2025 Aide Memoire is available on the \u201cInvestors\u201d page on its website. Q1 2025 Aide Memoire Teva has prepared this document to assist in the financial modeling of its quarterly results. The document is based on Teva\u2019s prior results, management\u2019s previous commentary about Teva\u2019s business outlook and data from select independent sources. Going forward, it is Teva\u2019s intention to provide this information towards the end of each quarter. About Teva Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) is a different kind of global biopharmaceutical leader, one that operates across the full spectrum of innovation to reliably deliver &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/teva-releases-q1-2025-aide-memoire\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Teva Releases Q1 2025 Aide Memoire&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-830925","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Teva Releases Q1 2025 Aide Memoire - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/teva-releases-q1-2025-aide-memoire\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Teva Releases Q1 2025 Aide Memoire - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"TEL AVIV, Israel, March 27, 2025 (GLOBE NEWSWIRE) &#8212; Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that its Q1 2025 Aide Memoire is available on the \u201cInvestors\u201d page on its website. Q1 2025 Aide Memoire Teva has prepared this document to assist in the financial modeling of its quarterly results. The document is based on Teva\u2019s prior results, management\u2019s previous commentary about Teva\u2019s business outlook and data from select independent sources. Going forward, it is Teva\u2019s intention to provide this information towards the end of each quarter. About Teva Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) is a different kind of global biopharmaceutical leader, one that operates across the full spectrum of innovation to reliably deliver &hellip; Continue reading &quot;Teva Releases Q1 2025 Aide Memoire&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/teva-releases-q1-2025-aide-memoire\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-03-27T21:10:06+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTA3NjYxOSM0MDIxMDM0MzcjMjAwMzA3Nw==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/teva-releases-q1-2025-aide-memoire\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/teva-releases-q1-2025-aide-memoire\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Teva Releases Q1 2025 Aide Memoire\",\"datePublished\":\"2025-03-27T21:10:06+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/teva-releases-q1-2025-aide-memoire\\\/\"},\"wordCount\":430,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/teva-releases-q1-2025-aide-memoire\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMTA3NjYxOSM0MDIxMDM0MzcjMjAwMzA3Nw==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/teva-releases-q1-2025-aide-memoire\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/teva-releases-q1-2025-aide-memoire\\\/\",\"name\":\"Teva Releases Q1 2025 Aide Memoire - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/teva-releases-q1-2025-aide-memoire\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/teva-releases-q1-2025-aide-memoire\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMTA3NjYxOSM0MDIxMDM0MzcjMjAwMzA3Nw==\",\"datePublished\":\"2025-03-27T21:10:06+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/teva-releases-q1-2025-aide-memoire\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/teva-releases-q1-2025-aide-memoire\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/teva-releases-q1-2025-aide-memoire\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMTA3NjYxOSM0MDIxMDM0MzcjMjAwMzA3Nw==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMTA3NjYxOSM0MDIxMDM0MzcjMjAwMzA3Nw==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/teva-releases-q1-2025-aide-memoire\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Teva Releases Q1 2025 Aide Memoire\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Teva Releases Q1 2025 Aide Memoire - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/teva-releases-q1-2025-aide-memoire\/","og_locale":"en_US","og_type":"article","og_title":"Teva Releases Q1 2025 Aide Memoire - Market Newsdesk","og_description":"TEL AVIV, Israel, March 27, 2025 (GLOBE NEWSWIRE) &#8212; Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that its Q1 2025 Aide Memoire is available on the \u201cInvestors\u201d page on its website. Q1 2025 Aide Memoire Teva has prepared this document to assist in the financial modeling of its quarterly results. The document is based on Teva\u2019s prior results, management\u2019s previous commentary about Teva\u2019s business outlook and data from select independent sources. Going forward, it is Teva\u2019s intention to provide this information towards the end of each quarter. About Teva Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) is a different kind of global biopharmaceutical leader, one that operates across the full spectrum of innovation to reliably deliver &hellip; Continue reading \"Teva Releases Q1 2025 Aide Memoire\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/teva-releases-q1-2025-aide-memoire\/","og_site_name":"Market Newsdesk","article_published_time":"2025-03-27T21:10:06+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTA3NjYxOSM0MDIxMDM0MzcjMjAwMzA3Nw==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/teva-releases-q1-2025-aide-memoire\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/teva-releases-q1-2025-aide-memoire\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Teva Releases Q1 2025 Aide Memoire","datePublished":"2025-03-27T21:10:06+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/teva-releases-q1-2025-aide-memoire\/"},"wordCount":430,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/teva-releases-q1-2025-aide-memoire\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTA3NjYxOSM0MDIxMDM0MzcjMjAwMzA3Nw==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/teva-releases-q1-2025-aide-memoire\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/teva-releases-q1-2025-aide-memoire\/","name":"Teva Releases Q1 2025 Aide Memoire - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/teva-releases-q1-2025-aide-memoire\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/teva-releases-q1-2025-aide-memoire\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTA3NjYxOSM0MDIxMDM0MzcjMjAwMzA3Nw==","datePublished":"2025-03-27T21:10:06+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/teva-releases-q1-2025-aide-memoire\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/teva-releases-q1-2025-aide-memoire\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/teva-releases-q1-2025-aide-memoire\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTA3NjYxOSM0MDIxMDM0MzcjMjAwMzA3Nw==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTA3NjYxOSM0MDIxMDM0MzcjMjAwMzA3Nw=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/teva-releases-q1-2025-aide-memoire\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Teva Releases Q1 2025 Aide Memoire"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/830925","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=830925"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/830925\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=830925"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=830925"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=830925"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}